Discovery of novel cancer immunotherapeutics

• Unité de recherche: INNOSUISSE
• Numéro de projet: 38502.1 IP-LS
• Titre du projet anglais: Discovery of novel cancer immunotherapeutics

Description succincte (Allemand)

Discovery of novel cancer immunotherapeutics

Description succincte (Anglais)

Discovery of novel cancer immunotherapeutics

Résumé des résultats (Abstract) (Allemand)

Antibody-based therapies have revolutionized the treatment of hematopoeitic malignancies. However, most patients relapse and become refractory to treatment due to antigen loss. The project aims is to discover therapies that target a newly identified cancer marker overexpressed in multiple cancers.